A once-weekly GLP-1 receptor agonist used in provider-guided weight-management programs.
Semaglutide mimics GLP-1 (glucagon-like peptide-1), a hormone your gut naturally releases after eating. It helps regulate appetite, slows stomach emptying, and supports healthy blood-sugar control, which together can reduce hunger and help you feel full sooner.
It is taken as a small once-weekly subcutaneous injection. Your provider starts you at a low dose and increases it gradually to balance results with tolerability.
Compounded semaglutide is prepared by a licensed compounding pharmacy. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety or effectiveness. They are dispensed only pursuant to a valid prescription from a licensed provider for an individual patient.

Most are mild to moderate and often ease as your body adjusts. Tell your provider about anything that concerns you.
Nausea
Constipation or diarrhea
Fatigue
Injection-site reactions
Safety: Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Seek care for severe abdominal pain (possible pancreatitis) or signs of an allergic reaction. This is not a complete list of risks, review all warnings with your provider.
A licensed provider will review your health profile and let you know.
Start the assessment